Mechanisms of gefitinib-induced interstitial pneumonitis: why and how the TKI perturbs innate immune systems?

Oncotarget. 2021 Jun 22;12(13):1321-1322. doi: 10.18632/oncotarget.27958.
No abstract available

Keywords: NLRP3 inflammasome; gefitinib; inflammation; interstitial pneumonitis; tyrosine kinase inhibitor.

Publication types

  • Editorial